Anne-Sophie Malapert

📢Meet Katrin Wuelfing, one of our Senior Scientist & our Transfer Project Leader ! 1) What do you do at AdhexPharma ? I am a Senior Scientist & Transfer Project Leader at AdhexPharma, which means that I am responsible for transferring products, that have already been commercialized on the market, to our production site in Chenôve at AdhexPharma. I am involved from the first enquiry from a new customer until the product is manufactured in Chenôve, which also involves regular contact with our customers, e.g. with regular meetings to ensure that the project is on track and the transfer is successful.    2) What is your favorite benefit of planar dosage forms ? One of my favorite benefits is that planar dosage forms offer a convenient alternative to other dosage forms such as injections or tablets. Patients can use films and patches themselves without the need for someone to assist them (e.g. with injections) and it is much easier to use, as it is difficult for people who have difficulty swallowing pills, for example. This gives each patient much more independence and freedom.   3) Can you tell us three things on your bucket list ? Crossing the alps on foot Exploring Canada by car, foot and train Start horseback riding again   #projectmanagement #management #pharma #expert #scientist #science #healthcare #innovation

30

Opportunity

3

Because at Laboratoires Pierre Fabre we care about women, we are proud and delighted to host an exclusive symposium on Overactive Bladder Management in Women ! Pierre Fabre Pharmaceutical Care will be present at the EUGA European Urogynaecological Association congress, taking place in Prague from 5th to 7th December. Our symposium, led by 3 renown speakers (Andrea Braga, Montserrat Epuna Pons and Maurizio Serati) will delve into the latest strategies and advancements in the management of overactive bladder in women (OAB). A key topic, as this condition can deeply affects their quality of life. This symposium is another step forward, sustaining a 42 years commitment to urology. #Urology #OveractiveBladder #wecareaboutwomen #OAB #MedicalSymposium #PierreFabre #HealthcareInnovation

14

💊 Of course, Medicinal Chemistry is essential for Pharmacists! ⚗   🔎Discover our 7th example of professionally relevant medicinal chemistry skills to enhance professional practice in the pharmaceutical sector. ⚗ 💊   🚀 🙌 Let’s go this week with: “Anticipating putative physicochemical incompatibility within a solute or by combining API for example during perfusion”, a skill more dedicated for pharmaceutical profession in dispensing pharmacies and hospitals.   👉 To know more about the skills framework: https://lnkd.in/evR38G5F   #medchem #skills #AFECT #teaching #pharmacy

19

[LabTalk – Unveiling Cosmetic Secrets] We are excited to announce the latest episode of LabTalk, Eurofins Cosmetics & Personal Care' podcast dedicated to innovations and safety in cosmetics. In this episode, Wagma Amini, Manager of Eurofins’ Cosmetics Lab in Canada, takes us through an important and concerning topic: benzene in cosmetic products. Did you know that benzene, a Group 1 carcinogen like asbestos and lead, can be found in everyday products? From aerosol propellants to the breakdown of ingredients like benzoyl peroxide, the risks of exposure are real. Proper storage and stability testing are crucial when it comes to benzene contamination. High temperatures and petroleum-based chemicals are common culprits. Tune in to this insightful episode as we explore the dangers of benzene and how we can detect it to ensure consumer safety. Listen now and stay tuned for future episodes! Contact us ➡ [email protected] #eurofins #LabTalk #Podcast #Cosmetics #Benzene #GlobalExpertisePersonalTouch

50

2 commentaires

We’re excited to share the latest episode of Eurofins Cosmetics & Personal Care's podcast, LabTalk! In this episode the presence of benzene in cosmetic products is discussesed. Benzene contamination can occur from aerosol propellants or ingredient breakdowns. Proper storage and testing are key to ensuring safety, especially when dealing with high temperatures and petroleum-based chemicals. Tune in to learn about benzene risks and detection methods to protect consumers. Listen now and stay updated! #eurofins #cosmeticsregulations #labeling #GlobalExpertisePersonaTouch #testingforlife #cosmeticproducts #cosmetic #testing #productsafety #productquality #canada #benzenefree #stabilitystudies

5

[Hair Testing - Ex vivo hair models] At Eurofins Cosmetics & Personal Care, we are pioneers in hair care testing on ex vivo hair models. These state-of-the-art testing methods provide invaluable information for cosmetic product development. Two ex vivo hair models : ◾ Human scalp explants : Perfect for assessing various dermo-cosmetic claims and evaluating product protection against exogenous stress factors such as pollution (including heavy metals, hydrocarbons, diesel particulate matter, ozone, and cigarette smoke) with comprehensive analysis via histology, transcriptomics (AHR, NRF2 pathways), and biochemical assays (MDA). ◾ Isolated human scalp hairs : Ideal for evaluating various dermo-cosmetic claims, including detailed assessments of hair growth. Our ex vivo hair models are meticulously designed to provide robust and reliable data, ensuring your products meet the highest standards of efficacy and safety. To find out more ➡ https://lnkd.in/dpvjB-5 #eurofins #Hair #ExVivoHairModels #Innovation #Dermocosmetics #GlobalExpertisePersonalTouch

26

👩‍🔬 Human lymphoid organs on a chip for preclinical vaccine trials, science fiction? 👏 Not for Lisa Chakrabarti's team at Institut Pasteur, labelled by Le Réseau des Carnot, who have developed this tool to simulate the human immune response on a chip and assess the efficacy of vaccine boosters ⤵️ Read the publication : https://lnkd.in/egXiE6Fn

1

Some great insights from Prof. Chantal Henry, about the challenges of diagnosing bipolar disorder. For our English-speaking followers, we collected the key highlights below: 💡 Delayed Diagnosis and Its Consequences - It takes an average of 8 to 10 years to make the diagnosis of bipolar disorder. - Around 60% of patients will begin their illness with one or more depressions, and for them the symptoms of exaltation are extremely moderate or in any case these symptoms are not perceived as pathological by the patients and so they will not report them to the doctor. - These patients will only seek care during the depressive phases, making it complicated for the doctor to make a diagnosis of bipolar disorder. 💡 The delayed diagnosis of bipolar disorder can have grave consequences: - The first risk is suicide, as 15% of untreated bipolar patients commit suicide. - The delay in diagnosis also means that associated disorders can develop, such as addiction, anxiety, and professional/social disintegration due to work stoppages, hospitalizations, and episodes that prevent the patient from functioning. 💡 A Major Innovation: Biological Blood Test - Until now, there has been no test of this type in psychiatry. - Having a biological blood test is a major innovation that can help improve the diagnosis of bipolar disorder. Prof. Henry is the scientific director of the Pierre Daniker foundation and a psychiatrist at GHU Paris psychiatrie & neurosciences, partner in the EDIT-B Consortium. #EuropeanMentalHealthWeek #BipolarDisorder #PrecisionPsychiatry SYNLAB Italia SYNLAB International Hospital Clínic de Barcelona Fundació de Recerca Sant Joan de Déu Fundació Clínic per a la Recerca Biomèdica Parc Sanitari Sant Joan de Deu Capital Region of Denmark ProductLife Group EIT Health EIT Health France EIT Health InnoStars EIT Health Spain Azapharm

17

3 commentaires

🚀 💯 🌏 Last week, our CEO Sofie Piepers embarked on a "Tour de France" for several interactive training sessions on #selective #treatment of #clinical #mastitis with BINET Frédéric, Alizée Deriviere, Christine Monchy, and Stephanie D'ESQUERMES of Vetoquinol France. The approach focused on elucidating, through 10 practical examples, all factors influencing the success or failure of mastitis #treatment and thus our treatment decisions. 🐄 What is selective treatment of clinical mastitis? 🐄 How can selective treatment of clinical mastitis help us towards a more responsible and lower use of #antibiotics? 🐄 What do we need to implement selective treatment of clinical mastitis in practice? 🐄 What are the #opportunities for farm vets? 🐄 Are there any precautions and prerequisites to take into consideration? 🔍 Expectations and conclusions: ✅ 25 to 40% lower use of antibiotics. ✅ No negative effects on clinical or bacteriological cure or any other future performances of the cow. ✅ Significant less days milk out of tank. 💡 ❗ ❗ ❗ ❗ 🙄 😯 Look at the example below (Case 10...). An example straight from a farm that is immediately treating every cow with clinical mastitis according to a strict protocol. What a waste of antibiotics (31.000 mg ❗), milk (at least 154 kg ❗) and money... This can be avoided by switching to selective treatment of non-severe cases of clinical mastitis.

2

Bonjour à tous👋, Je vous recommande de suivre notre dernier webinar sur l'analyse des Nitrosamines. Il est planifié le 14 novembre. Toutes les indications sont en dessous, il suffit simplement de cliquer sur le lien. Pharmaceutiquement 👋 💊 Corentin GENY ----------------------------------------------------------- 🔈Join us on November 14 for a virtual roundtable discussion on 𝗡𝗶𝘁𝗿𝗼𝘀𝗮𝗺𝗶𝗻𝗲 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗣𝗵𝗮𝗿𝗺𝗮 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆. Register now to secure your spot: https://okt.to/EnXrke LGC Standards is sponsoring this exclusive webinar hosted by The Analytical Scientist, featuring top experts from AbbVie, Almac, and the FDA. Our distinguished panel will discuss critical topics, including: 1️⃣Overcoming the major challenges in detecting nitrosamines 2️⃣Current techniques and technologies 3️⃣How to build a robust method for nitrosamine analysis 4️⃣The impact of recent regulatory changes on the industry 5️⃣Future trends in nitrosamine testing and regulatory landscapes ⏲️November 14 | 10 am EST | 3 pm GMT Gain insights from leading voices in pharmaceutical analysis and stay ahead of the latest trends in nitrosamine testing. #NitrosamineTesting #PharmaceuticalAnalysis #pharmaindustry

8

The National Biosafety Agency of Burkina Faso published on August 30, 2024 a press release about the biosafety measures taken in the implementation of the Target Malaria project in Burkina Faso at the Institut de Recherche en Sciences de la Santé (Burkina Faso) in Bobo-Dioulasso. This release calls on the Burkina Faso public to trust the decisions made my Burkinabè regulatory agencies authorising research on genetically modified mosquitoes as part of the Target Malaria project. “ANB, in this statement, wishes to reassure national and international public opinion that all biosafety measures have been taken to ensure the safe use of these GMOs both in a contained environment (in the laboratory) and in an open environment (in the environment), for each stage of the project's development. It also invites the public to have confidence in the state structures and authorities set up to coordinate, develop, monitor and use research for the benefit of our well-being and the development of our country, and to distance themselves from scientific untruths, in particular the conflation of Anopheles mosquitoes, the vectors of malaria (the subject of the Target Malaria project), and Aedes mosquitoes, the vectors of dengue fever”. Full release (in French): https://lnkd.in/e8nnv_HX Target Malaria supports and scrupulously respects stringent, competent, responsible and transparent regulations to advance research into the use of genetically modified mosquitoes to combat malaria in Burkina Faso and Africa. This statement reinforces the strong declaration made by the National Academy of Sciences, Arts and Letters in August 2024 #malariaresearch #endmalaria #zeromalaria #genedrive

8

1 commentaire

[EU tightens retinol rules: Eurofins C&PC guides you through the changes!] Today, retinol is widely used in the skin care industry. It is recognised for its anti-aging, anti-acne and cell renewal properties. The European Commission Regulation (EU) 2024/996, adopted on the 3rd of April, 2024, introduces new measures for the marketing and use of retinol in cosmetic products in the European Union. Eurofins Cosmetics & Personal Care is committed to guiding and supporting you through these regulatory changes. Read more ➡ https://lnkd.in/gWqz66JT #eurofins  #retinol #regulatory #cosmetics #GlobalExpertisePersonalTouch

12

"Pasteur Pipettes Market 𝐒𝐢𝐳𝐞 𝐀𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 Pasteur Pipettes Market size is expected to develop revenue and exponential market growth at a remarkable CAGR during the forecast period from 2024–2031. ➢𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐦𝐞𝐧𝐭𝐢𝐨𝐧𝐞𝐝 𝐚𝐬 𝐛𝐞𝐥𝐨𝐰: ➢> Institut Pasteur > Sanofi Pasteur MSD > Obra Social Luis Pasteur > University of Strasbourg > Institut Pasteur de Madagascar > Institut Pasteur de Dakar > Institut Pasteur de Tunis - معهد باستور تونس > Groupe Pasteur Mutualité > CLINIQUE PASTEUR Toulouse > Pasteur Network > Institut Pasteur de Lille > Pasteur Institute > Pasteur Institute of Iran > PASTEUR MEDICAL > Institut Pasteur d'Algérie > Institut Pasteur de Montevideo > Lycée Pasteur Mont-Roland > Centre Pasteur du Cameroun (CPC) > Clínica Pasteur Neuquén > ASSOCIATION PAJE | Pasteur Avenir JEunesse > Louis Pasteur Santé > Clínica Pasteur > Laboratorio Pasteur > Farmacias Pasteur Colombia > Louis Pasteur High School > Louis Pasteur Private Hospital > Farmacias Pasteur Colombia > Polyclinique Pasteur Groupe Cap Santé > Groupe Pasteur Mutualité > Clínica Pasteur, Desarrollo del Capital Humano #data #sales #marketresearch #research #entrepreneur #businessstrategy #technology #data #sales #datacollection #salesfunnel #contentmarketing #bhfyp #size #forecast # #Share #Scope #Opportunities #Analysis #PasteurPipettes"

12

💊 Of course, Medicinal Chemistry is essential for Pharmacists! ⚗ 🔎Discover our 1st example of professionally relevant medicinal chemistry skills to enhance professional practice in the pharmaceutical sector. ⚗ 💊 🚀 🙌 Let’s go this week with: “Linking the chemical structure of an Active Pharmaceutical Ingredients (API) to its physicochemical properties”, a skill more dedicated for pharmaceutical profession in industry and R&D. 👉 To know more about the skills framework: https://lnkd.in/evR38G5F #medchem #skills #AFECT #teaching #pharmacy

42

[WEBINAR] 📅 On July 11th, Jean-Michel Delaval (Newtone Technologies), Marta Bertolini, PhD (Monasterium Laboratory Skin & Hair Research Solutions GmbH) & Séverine Thibaut de Ménonville 🧪 🧬 (QIMA Life Sciences) presented a webinar on 𝗗𝗲𝗿𝗺𝗮𝘁𝗼𝗹𝗼𝗴𝘆 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗮𝗻𝗱 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁.   💻 If you missed this #Webinar, or if you would simply like to watch it again, you can access the recording here: https://lnkd.in/eYVq7SjF   👩‍🔬 In this presentation, you will: - Learn about the benefits of collaborating with CROs for drug discovery & development projects - Explore 9 different case studies spanning all stages of the drug discovery and development process, involving several different skin conditions and diseases   By the end, you will have discovered how our established and custom-developed models and tests have benefited other dermatology projects in the past – and how they could soon benefit yours! ✨   #Dermatology #DrugDiscovery #DrugDevelopment

17

1 commentaire

🌱👩‍🔬 𝐈𝐧𝐯𝐞𝐬𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐞 𝐍𝐞𝐱𝐭 𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 👨‍🔬🌱 On November 7th, we had the pleasure of welcoming chemistry students from HEPL - Haute Ecole de la Province de Liège on both of our sites. Through a mix of theoretical presentations on our activities and tours of different laboratories, students discovered: 🔬 The different activities of the analytical laboratory (Food Safety, GLP Pre-clinical and R&D) and the journey of a sample in our analytical lab, from logistics to advanced analysis using equipment like UPLC-MS/MS, GC-MS/MS, HRMS, and immunoassay tools. At each step, we introduced the professionals behind the work, underlining the challenges they have, daily tight deadlines, flexibility, and multidisciplinary collaboration. We emphasized how their collective expertise positions CER Groupe as a laboratory of reference. 🧬 Key processes like biologics production, bioreactors for recombinant protein growth, and purification technologies. 🤝 The collaboration between research, production, and preclinical teams ensures project management and innovation. We also highlighted opportunities for internships and master's projects, emphasizing how CER Groupe supports the development of tomorrow’s talent by bridging academic knowledge with industry expertise. The students' thoughtful questions—on topics like biologics development costs and ensuring analysis integrity—showed their curiosity and alignment with the challenges we have daily. #CERGroupe #Training #Innovation #Bioproduction #Agrotech #YoungTalents #PreclinicalResearch #Students #HEPLvisit

38

Thierry de Fougerolles from our Healthcare team has just published an article on our innovative methodology #healthcarbonomics to estimate the impact of medicines and vaccines on the carbon footprint of healthcare systems. ➡ Read more in the lead below in Décideurs Magazine #cvaviews #sustainability #newhealthcaresystems https://lnkd.in/gJA4cvA7

9